Friday, February 13, 2009
Drug giant GlaxoSmithKline pledges cheap medicine for world's poor
Guardian.co.uk, the new head of GlaxoSmithKline, Andrew Witty, has told the Guardian he will slash prices on all medicines in the poorest countries, give back profits to be spent on hospitals and clinics and – most ground-breaking of all – share knowledge about potential drugs that are currently protected by patents. How will this affect the marketing and distribution budgets of GSK? Will we see a rise in social awareness/social networking, etc as they embark on this change? Please share your thoughts.